CurveBeam AI (ASX:CVB) Total Assets : A$70.77 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Total Assets?

CurveBeam AI's Total Assets for the quarter that ended in Dec. 2023 was A$70.77 Mil.

Total Assets is connected with ROA %. CurveBeam AI's annualized ROA % for the quarter that ended in Dec. 2023 was -42.88%. Total Assets is also linked to Revenue through Asset Turnover. CurveBeam AI's Asset Turnover for the quarter that ended in Dec. 2023 was 0.05.

CurveBeam AI Total Assets Historical Data

The historical data trend for CurveBeam AI's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Total Assets Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

Total Assets

61.36

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
Total Assets	-	-	-	61.36	70.77

CurveBeam AI Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

CurveBeam AI's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	-48.1	+	109.464
	=	61.36

CurveBeam AI's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	46.926	+	23.843
	=	70.77

CurveBeam AI (ASX:CVB) Total Assets Explanation

Total Assets is connected with ROA %.

CurveBeam AI's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-28.332	/	( (61.363	+	70.769)	/ 2 )
	=	-28.332	/	66.066
	=	-42.88 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

CurveBeam AI's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	3.418	/	( (61.363	+	70.769)	/ 2 )
=	3.418	/	66.066
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

CurveBeam AI Total Assets Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines